EI-1941-1 and -2, novel interleukin-1β converting enzyme inhibitors produced by Farrowia sp. E-1941. II. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties

Journal of Antibiotics

Volumn 56, Issue 7, 2003, Pages 603-609

  Koizumi, Fumito ^a   Ishiguro, Hiroki ^a   Ando, Katsuhiko ^a   Kondo, Hidemasa ^a   Yoshida, Mayumi ^a,b   Matsuda, Yuzuru ^a   Nakanishi, Satoshi ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

^b RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; E1 1941 1; E1 1941 2; E1 1941 3; EI 1941 1; EI 1941 2; EI 1941 3; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DECOMPOSITION; DRUG ISOLATION; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FARROWIA; FUNGAL STRAIN; HUMAN; IC 50; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TAXONOMY;

FARROWIA;

EID: 0041529865     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.56.603     Document Type: Article

References (17)

1. Dinarello, C. A.: Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652, 1991
2. Dinarello, C. A. & S. M. Wolff: The role of interleukin-1 in disease. N. Engl. J. Med. 328: 106-113, 1993
3. Thornberry, N. A.; H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, K. O. Elliston, J. M. Ayala, F. J. Casano, J. Chin, G. J.-F. Ding, L. A. Egger, E. P. Gaffney, G. Limjuco, O. C. Palyha, S. M. Raju, A. M. Rolando, J. P. Salley, T.-T. Yamin, T. D. Lee, J. E. Shively, M. Maccross, R. A. Mumford, J. A. Schmidt & M. J. Tocci: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356: 768-774, 1992
4. Gerretti, D. P.; C. J. Kozlosky, B. Mosley, N. Nelson, K. V. Ness, T. A. Greenstreet, C. J. March, S. R. Kronheim, T. Druck, L. A. Cannizzaro, K. Huebner & R. A. Black: Molecular cloning of the interleukin-1β converting enzyme. Science 256: 97-100, 1992
5. Elford, P. R.; R. Heng, L. Révész & A. R. Mackenzie: Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224-015, an inhibitor of the interleukin-1β converting enzyme. British J. Pharmacol. 115: 601-606, 1995
6. Ku, G.; T. Faust, L. L. Lauffer, D. J. Livingston & M. W. Harding: Interleukin-1β converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine 8: 377-386, 1996
7. Tsukuda, E.; T. Tanaka, K. Ochiai, H. Kondo, M. Yoshida, T. Agatsuma, Y. Saitoh, S. Teshiba & Y. Matsuda EI-1507-1 and -2, novel interleukin-1β converting enzyme inhibitors produced by Streptomyces sp. E-1507. J. Antibiotics 49: 333-339, 1996
8. Tanaka, T.; E. Tsukuda, K. Ochiai, H. Kondo, S. Teshiba & Y. Matsuda: EI-1511-3, -5 and EI-1625-2, novel interleukin-1β converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. I. Taxonomy of producing strain, fermentation and isolation. J. Antibiotics 49: 1073-1078, 1996
9. Uosaki, Y.; T. Agatsuma, T. Tanaka & Y. Saitoh: EI-1511-3, -5 and EI-1625-2, novel interleukin-1β converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. II. Structure determination. J. Antibiotics 49: 1079-1084, 1996
10. Tanaka, T.; E. Tsukuda, Y. Uosaki & Y. Matsuda: EI-1511-3, -5 and EI-1625-2, novel interleukin-1β converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. III. Biochemical properties of EI-1511-3, -5 and EI-1625-2. J. Antibiotics 49: 1085-1090, 1996
11. 2 homodimer. Cell 78: 343-352, 1994
12. Hawksworth, D. L.: Farrowia, a new genus in the Chaetomiaceae. Persoonia 8: 167-185, 1975
13. Gehrt, A.; G. Erkel, H. Anke, T. Anke & O. Sterner: New hexaketide inhibitors of eukaryotic signal transduction. Natl. Prod. Lett. 9: 259-264, 1997
14. Gehrt, A.; G. Erkel, T. Anke & O. Sterner: Cycloepoxydon, 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction. J. Antibiotics 51: 455-463, 1998
15. Baeuerle, P. A. & T. Henkel: Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179, 1994
16. Salvatore, M. J.; O. D. Hensens, D. L. Zink, J. Liesch, C. Dufresne, J. G. Ondeyka, T. M. Jürgens, R. P. Borris, S. Raghoobar, E. McCauley, L. Kong, S. E. Gartner, G. E. Koch, F. Pelaez, M. T. Diez, C. Cascales, I. Martin, J. D. Polishook, M. J. Balick, H. T. Beck, S. R. King, A. Hsu & R. B. Lingham: L-741,494, a fungal metabolite that is an inhibitor of interleukin-1β converting enzyme. J. Natur. Prod. 57: 755-760, 1994
17. Matsumoto, T.; A. Ishiyama, Y. Yamaguchi, R. Masuma, H. Ui, K. Shiomi, H. Yamada & S. Omura: Novel cyclopentanone derivatives pentenocins A and B, with interleukin-1β converting enzyme inhibitory activity, produced by Trichoderma hamatum FO-6903. J. Antibiotics 52: 754-757, 1999